Perimenopause and Joint Pain: The Estrogen-Inflammation Connection

MARKABLE Research Team · May 2026 · 7 min read

You wake up and your hands are stiff. Your knees ache when you climb stairs. Your shoulder has developed a dull, persistent pain that wasn't there six months ago. You might be thinking about arthritis, overuse, or just "getting older." But if you're in your 40s or early 50s, there's a significant possibility that what you're feeling is driven by hormonal changes.

Joint pain is one of the most common symptoms of perimenopause, yet it is among the least discussed. Research suggests it affects a substantial proportion of women during the hormonal transition, and it is frequently attributed to other causes.

50%+

of women in midlife report joint or musculoskeletal symptoms

Source: Szoeke CEI et al., Climacteric, 2008 (Melbourne Women's Midlife Health Project)

Why estrogen matters for your joints

Estrogen is not just a reproductive hormone. It plays a critical role in musculoskeletal health, and its decline during perimenopause has direct effects on joints, tendons, and connective tissue.

Anti-inflammatory protection

Estrogen has well-documented anti-inflammatory properties. It modulates the immune system by regulating cytokines, the signaling molecules that drive inflammation. When estrogen levels drop, the inflammatory response can become dysregulated, leading to increased joint inflammation even in the absence of injury or disease.

Research has shown that estrogen receptors are present in joint tissues, including cartilage, synovial membrane, and ligaments. When estrogen levels fluctuate or decline, these tissues lose a key source of protection against inflammatory damage.

Collagen and connective tissue

Estrogen stimulates collagen production, which is essential for the structural integrity of cartilage, tendons, and ligaments. As estrogen declines, collagen synthesis slows. This affects not just skin (where it is more visibly apparent) but also the connective tissues within and around joints.

Reduced collagen means less cushioning, less elasticity, and greater susceptibility to wear. Joints that were previously asymptomatic may begin to feel stiff, sore, or unstable.

Fluid and lubrication

Estrogen also influences the production of synovial fluid, the lubricant that allows joints to move smoothly. Reduced estrogen can lead to decreased synovial fluid production, contributing to the stiffness and discomfort that many perimenopausal women describe, particularly in the morning.

Where perimenopause joint pain typically shows up

While perimenopause-related joint pain can affect any joint, certain areas are more commonly involved:

Hands and fingers (stiffness)
Knees (aching, stiffness)
Shoulders (pain, reduced range)
Hips (deep aching)
Wrists (weakness, pain)
Lower back (stiffness)
Neck (tension, pain)
Feet and ankles (morning stiffness)

The frozen shoulder connection

Adhesive capsulitis, commonly known as frozen shoulder, deserves special attention in the context of perimenopause. This condition, characterized by progressive stiffness and pain in the shoulder joint, has a striking demographic profile: it disproportionately affects women between the ages of 40 and 60.

Research has explored the hormonal connection. A study published in the Journal of Shoulder and Elbow Surgery found that frozen shoulder incidence correlates with the perimenopausal and early postmenopausal window. The hypothesized mechanism involves estrogen's role in maintaining the flexibility of the joint capsule. When estrogen declines, the capsule may thicken and contract, leading to the characteristic restriction of movement.

A common scenario: A woman in her mid-40s develops shoulder pain that gradually worsens over months. She is treated for rotator cuff injury or referred for physiotherapy. The hormonal contribution is rarely considered. Yet understanding the hormonal context can influence both treatment approach and expectations for recovery.

Distinguishing hormonal joint pain from other conditions

Joint pain during perimenopause can look and feel similar to other conditions. It is important to work with a healthcare provider to consider the full picture. Key conditions to rule out include:

Rheumatoid arthritis (RA)

RA is an autoimmune condition that can emerge or flare during perimenopause. Key distinguishing features include symmetrical joint involvement, prolonged morning stiffness (more than 30 minutes), visible joint swelling, and elevated inflammatory markers on blood tests (CRP, ESR, anti-CCP antibodies).

Osteoarthritis

Osteoarthritis involves wear-and-tear damage to joint cartilage. It tends to affect weight-bearing joints and those with previous injury. It worsens with use throughout the day, unlike hormonal joint pain, which is often worst in the morning and improves with movement.

Thyroid dysfunction

Hypothyroidism, which is more common in women during midlife, can cause joint pain and stiffness that mimics hormonal joint symptoms. A simple blood test (TSH) can help rule this out.

Vitamin D deficiency

Low vitamin D levels are common in midlife women and can cause musculoskeletal pain. Supplementation can resolve symptoms if deficiency is confirmed.

When to seek evaluation: If your joint pain is accompanied by visible swelling, redness, warmth, fever, significant weight loss, or symptoms that are progressively worsening despite self-care measures, see your healthcare provider promptly. These may indicate a condition that requires specific treatment.

What helps: evidence-based approaches

Movement and exercise

Regular physical activity is consistently supported by research as one of the most effective interventions for perimenopause joint pain. Key approaches include:

Anti-inflammatory nutrition

Dietary approaches that reduce systemic inflammation may help manage joint symptoms:

Hormone therapy

For some women, hormone therapy (HT) can significantly improve joint symptoms by addressing the underlying estrogen decline. The Women's Health Initiative and subsequent studies have shown that estrogen therapy can reduce joint pain and improve musculoskeletal outcomes. This is a conversation to have with your healthcare provider, weighing individual benefits and risks.

Targeted supplementation

Some supplements have evidence supporting their use for joint health, though quality and response vary:

Wondering if your symptoms are hormonal?

MARKABLE tracks hormonal wellness patterns through facial analysis, cognitive testing, and symptom monitoring. Understanding the pattern can help you and your provider choose the right approach.

Start My Free Check →

What to tell your healthcare provider

If you suspect your joint pain may be related to perimenopause, a structured conversation with your healthcare provider is the most productive next step. Consider sharing:

  1. When symptoms started and whether they correlate with any changes in your menstrual cycle
  2. The pattern of pain: Which joints are affected, when symptoms are worst, what makes them better or worse
  3. Other perimenopause symptoms you may be experiencing (sleep changes, mood changes, hot flashes, cycle irregularity)
  4. Your current activity level and any recent changes
  5. Family history of autoimmune conditions or osteoarthritis

This information helps your provider determine whether your symptoms are likely hormonal, whether further testing is needed, and what treatment approach makes sense for you.

The bottom line

Joint pain during perimenopause is real, common, and physiologically well-explained. Estrogen's decline affects inflammation, collagen, and joint lubrication in ways that can produce significant discomfort. The good news is that it is manageable. Movement, nutrition, and, where appropriate, hormonal approaches can make a substantial difference.

The first step is recognizing the connection. If your joints started hurting around the same time other things began shifting, it may not be a coincidence.

This article is for informational purposes only and does not constitute medical advice. MARKABLE is a general wellness product for personal awareness and self-monitoring. It is not a medical device and is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider for medical guidance.